Ariadne Receives SBIR Phase I Grant from NIH
Ariadne announced receiving a $100,000 SBIR Phase I grant from the NIH, National Center for Research Resources towards the further development of MedScan technology. MedScan employs natural language processing (NLP) to extract biomedical information from scientific text into databases amenable for computational analysis. The grant will be used to expand the scope of MedScan beyond its traditional focus on pathway analysis.
MedScan utilizes a high content linguistics approach to extract functional relationships between biological entities such as proteins, cell processes and small molecules from MEDLINE abstracts and full text articles. It recognizes types of regulatory mechanisms involved, the effects of regulation, and can be customized to extract other types of information and focus on different organisms.
The SBIR grant will be used to expand MedScan into the area of toxicology, small molecule-enzyme interactions, and human metabolism. The resulting knowledge base will have immediate impact and offer a high value proposition for early IND rejection as well as in biomarker discovery.
Other news from the department research and development

Get the life science industry in your inbox
By submitting this form you agree that LUMITOS AG will send you the newsletter(s) selected above by email. Your data will not be passed on to third parties. Your data will be stored and processed in accordance with our data protection regulations. LUMITOS may contact you by email for the purpose of advertising or market and opinion surveys. You can revoke your consent at any time without giving reasons to LUMITOS AG, Ernst-Augustin-Str. 2, 12489 Berlin, Germany or by e-mail at revoke@lumitos.com with effect for the future. In addition, each email contains a link to unsubscribe from the corresponding newsletter.